Wetenschappelijke publicaties

VisserO, Hulscher MEJL, l. Antonise-Kamp, R. Akkermans, K. van der Velden, RAC Ruiter, JLA Hautvast.Assessing determinants of the intention to accept a pertussis cocooning vaccination: A survey among healthcare workers in maternity and paediatric care. Vaccine 2018: 36 (5): 736-43.

Gudrun S. Freidl, Alma Tostmann, Moud Curvers, Wilhelmina L.M. Ruijs, Gaby Smits, Rutger Schepp, Erwin Duizer, Greet Boland, Hester de Melker, Fiona R.M. van der Klis, Jeannine L.A. Hautvast, Irene K. Veldhuijzen. Immunity against measles, mumps, rubella, varicella, diphtheria, tetanus, polio, hepatitis A and hepatitis B among adult asylum seekers in the Netherlands, 2016. Vaccine 2018: 36 (12): 1664-1672

K.V.C. Wevers, G. Puts, J.L.A. Hautvast, A. Tostmann, C.H.F.M. Waegemaekers(2018) Heropsporing van patiënten met chronische hepatitis B en C. Infectieziekten Bulletin. 2018; 29(1).

Ben Z Katz,Simon M Collin,Gabrielle Murphy, Rona Moss-Morris, Vegard Bruun Wyller, Knut-Arne Wensaas, Jeannine L.A. Hautvast,Chantal P Bleeker-Rovers, Ute Vollmer-Conna, Dedra Buchwald,Renée Taylor,Paul Little,Esther Crawley,Peter D White& Andrew Lloyd. The international collaborative on fatigue following infection (COFFI). Fatigue: Biomedicine, Health & Behavior. 2018; 6: 106-121. Published online: 19 Jan 2018

Janneke P Bil, Peter AG Schrooders, Maria Prins, Peter M Kouw, Judith HE Klomp, Maarten Scholing, Lutje PHM Huijbregts, Gerard JB Sonder, Toos CHFM Waegemaekers, Henry JC de Vries, Wieneke Meijer, Freke R Zuure, Alma Tostmann. Screening in newly arrived migrants: Integrating hepatitis B, hepatitis C and HIV screening into tuberculosis entry screening for migrants in the Netherlands, 2013 to 2015. Euro Surveill.2018;23(11):pii=17-00491.

Manon T. M. Pelgrim, Karlijn J. G. Kampman, Henny Rexwinkel.Alma Tostmann,  Jeannine L. A. Hautvast. Overwegingen om te kiezen voor een soa-test bij de GGD. Tijdschr Gezondheidswet (2018). https://doi.org/10.1007/s12508-018-0120-7

Carolina J G Kampman, Janneke C M Heijne, Petronella H M Kistemaker-Koedijk, Femke D H Koedijk, Maartje Visser, Jeannine L A Hautvast. Determinants of frequent and infrequent STI testing and STI diagnosis related to test frequency among men who have sex with men in the eastern part of the Netherlands: a 6-year retrospective study. BMJ Open2018;8:e020495. doi:10.1136/bmjopen-2017-020495

de Munter AC, Tostmann A, Hahné SJM, Spaan DH, van Ginkel R, Ruijs WLM.Risk factors for persisting measles susceptibility: a case-control study among unvaccinated orthodox Protestants.. Eur J Public Health.2018 Apr 30. doi: 10.1093/eurpub/cky072. [Epub ahead of print]

van Roeden SE¹, Reukers DFM², van Jaarsveld CHM², Kampschreur LM³, Hoepelman AIM¹, Wever PC⁴, Bleeker-Rovers CP⁵, Oosterheert JJ¹. Chronic Q fever: patientand treatment-relatedfactorsinfluencinglong-termquality of life. QJM.2018 Aug 9. doi: 10.1093/qjmed/hcy171. [Epub ahead of print]

Raven S, Urbanus A, de Gee A, Hoebe C, van Steenbergen J. Predictors of hepatitis B vaccination completion among people who use drugs participating in a national program of targeted vaccination. Vaccine. 2018 Aug 23;36(35):5282-5287. doi: 10.1016/j.vaccine.2018.07.045. Epub 2018 Jul 27.

Publicaties van medewerkers werkend bij AMPHI, maar publicatie in andere functie geschreven:

Janssen LMA, Tostmann A, Hopman J, Liem KD. 0.2% chlorhexidine acetate as skin disinfectant prevents skin lesions in extremely preterm infants: a preliminary report. Arch Dis Child Fetal Neonatal Ed. 2018 Mar;103(2):F97-f100

Martijn M Methorst, Annemarie A Uijen, Henk Schers, Waling P Tiersma, Jeannine LA Hautvastand Cornelia HM van JaarsveldIncidence, presentation and management of Lyme disease in Dutch general practice. Family Practice, 2018, 1–7

KE Stott, H Pertinez, MGG Sturkenboom, MJ Boeree, R. Aarnoutse, G. Ramachandran, A. Requena-Mendez,  C. Peloquin, C. F. N. Koegelenberg, J. W. C. Alffenaar, R. Ruslami, A. Tostmann, S. Swaminathan, H. McIlleron, and G. Davies. Pharmacokinetics of rifampicin in adult TB patients and healthy volunteers: a systematic review and meta-analysis. J Antimicrob Chemother, 2018 april (e-pub)  https://doi.org/10.1093/jac/dky152

Urineculturesand antibioticsfor urinary tract infectionsin Dutchgeneral practice.Ganzeboom KMJ¹, Uijen AA², Teunissen DTAM³, Assendelft WJJ⁴, Peters HJG⁵, Hautvast JLA⁶, Van Jaarsveld CHM⁷. Prim Health Care Res Dev.2018 Aug 31:1-8. doi: 10.1017/S146342361800066X. [Epub ahead of print]

Spaan DH, Ruijs WLM, Hautvast JLA, Tostmann A. Increase in vaccination coverage between subsequent generations of orthodox Protestants in The Netherlands. Eur J Public Health. 2017 Jan 23. doi: 10.1093/eurpub/ckw248.

Bosschart MH, Zweers S, Waegemaekers CHFM, Tostmann A. Vlekjes op het kinderdagverblijf  ‘geen vlek is te gek’. Infectieziekten Bulletin 2016; 28: 48-55.

Kusters T , Raven S, Jansen L, Nadi S, Hautvast J, Tostmann A. BRMO-casuïstiek in 2015: omvang en werkinzet bij 8 GGD’en. Infectieziekten Bulletin 2017; 28: 347-352.

Florisson A, Sterken Y, Haaijman J, Hautvast J, Feenstra S. BRMO-preventie: ervaringen van bewoners van verpleeg- en verzorgingshuizen.  Infectieziekten Bulletin 2017; 28.

Woudenberg T, van Binnendijk RS, Sanders EA, Wallinga J, de Melker HE, Ruijs WL, Hahné SJ. Large measles epidemic in the Netherlands, May 2013 to March 2014: changing epidemiology. Euro Surveill 2017 Jan 19;22(3). pii: 30443. doi: 10.2807/1560-7917

Freidl GS, Sonder GJ, Bovée LP, Friesema IH, van Rijckevorsel GG, Ruijs WL, van Schie F, Siedenburg EC, Yang JY, Vennema H. Hepatitis A outbreak among men who have sex with men (MSM) predominantly linked with the EuroPride, the Netherlands, July 2016 to February 2017. Euro Surveill. 2017 Feb 23;22(8). pii: 30468. doi: 10.2807/1560-7917.

Wouthuyzen-Bakker M, Knoester M, van den Berg AP, GeurtsvanKessel CH, Koopmans MP, Van Leer-Buter C, Oude Velthuis B, Pas SD, Ruijs WL, Schmidt-Chanasit J, Vreden SG, van der Werf TS, Reusken CB, Bierman WF. Yellow fever in a traveller returning from Suriname to the Netherlands, March 2017. Euro Surveill. 2017 Mar 16;22(11). pii: 30488. doi: 10.2807/1560-7917

Fievez LCR, Wong A, Ruijs WLM, Meerstadt-Rombach FS, Timen A. Cross-sectional study on factors hampering implementation of measles pre- and postexposure measures in Dutch hospitals during the 2013-2014 measles outbreak. Am J Infect Control. 2017 Jul 1;45(7):750-755. doi: 10.1016/j.ajic.2017.02.033. Epub 2017 May 16.

Duizer E, Ruijs WL, van der Weijden CP, Timen A. Response to a wild poliovirus type 2 (WPV2)-shedding event following accidental exposure to WPV2, the Netherlands, April 2017. Euro Surveill. 2017 May 25;22(21). pii: 30542. doi: 10.2807/1560-7917.ES.2017.22.21.30542.

Suijkerbuijk AWM, Swaan CM, Mangen MJ, Polder JJ, Timen A, Ruijs WLM. Ebola in the Netherlands, 2014-2015: costs of preparedness and response.  Eur J Health Econ. 2017 Nov 17. doi: 10.1007/s10198-017-0940-4. [Epub ahead of print]

Knol MJ,  Ruijs WLM,  de Melker HE, Berbers GAM, van der Ende A. Plotselinge toename van invasieve meningokokkenziekte serogroep W in 2015 en 2016. Infectieziektenbulletin 2017;28:23-28.

Hopman J, Tostmann A, Wertheim H, Bos M, Kolwijck E, Akkermans R, Sturm P, Voss A, Pickkers P, Vd Hoeven H. Reduced rate of intensive care unit acquired gram-negative bacilli after removal of sinks and introduction of ‘water-free’ patient care. Antimicrobial resistance and infection control. 2017;6:59.

Nic Lochlainn L, Ruijs WL, Swaan C, de Melker H, Hahne S. Response to Lim et al regarding “In-flight transmission of measles: Time to update the guidelines?”. Am J Infect Control. 2017 Jan 01;45(1):95-6.

O. Visser, M.E.J.L. Hulscher, L. Antonise-Kamp, R. Akkermans, K. van der Velden, R.A.C.Ruiter, J.L.A.Hautvast (2018). Assessing determinants of the intention to accept a pertussis cocooning vaccination: A survey among healthcare workers in maternity and paediatric care. Vaccine. 2018; 36 (5): 736-743.

van der Maas NA, Ruijs WL, Rots N, de Melker HE  (2017). Bescherming van de pasgeborene tegen kinkhoest; wat is de optimale strategie? Tijdschrift voor Infectieziekten, 2017;12:196-202

Joore IK, Reukers DFM, Donker GA, van Sighem AI, Op de Coul ELM, Prins JM, Geerlings SE, Barth RE, van Bergen JEAM, van den Broek IV. Missed opportunities to offer HIV tests to high-risk groups during general practitioners’ STI-related consultations: an observational study. BMJ Open 2016;6:e009194.

Morroy G. Reactie op ‘Niet meer moeheid na Q-koorts’ NTVG Januari 2016.

Tostmann A, Waegemaekers T, Hautvast J. Tele-ARENA AMPHI brengt epidemiologie naar het veld met low-tech telefonisch onderwijs. Infectieziektenbulletin 2016; 27(1):21-22

Hautvast J, Tostmann A, van der Velden J. Academische Werkplaats AMPHI stelt zich voor. Infectieziektenbulletin 2016; 27(1):16-20

Van Lier A, Tostmann A, Harmsen IA, de Melker HE, Hautvast JLA, Ruijs WLM. Negative attitude and low intention to vaccinate universally against varicella among public health professionals and parents in the Netherlands: two internet surveys. BMC Infect Dis. 2016 Mar 15;16:127.

Brandwagt DAH, Herremans T, Schneeberger PM, Hackert VH, Hoebe CJPA, Paget J, van der Hoek W. Waning population immunity prior to a large Q fever epidemic in the south of The Netherlands. Epidemiol Infect. 2016 Oct;144(13):2866-72.

Raven SFH, de Heus B, Wong A, Zaaijer HL and van Steenbergen JE (2016). Fluctuation of Viremia in Hepatitis B Virus–Infected Healthcare Workers Performing Exposure-Prone Procedures in the Netherlands. Infect Control Hosp Epidemiol. 2016 Jun;37(6):655-60.

Morroy G, Keijmel SP, Delsing CE, Bleijenberg G, Langendam M, Timen A, et al. (2016) Fatigue following Acute Q-Fever: A Systematic Literature Review. PLoS ONE 11(5): e0155884.

Schrooders P, Klomp J, Huijbregts L, Waegemaekers T, Tostmann A. (2016) Is koppeling van vrijwillige screening op hepatitis B en C aan de verplichte tuberculosescreening voor immigranten zinvol? Infectieziekten Bulletin. 2016 juni; 27(6):161-8.

Visser O, Hautvast JLA, van der Velden K, Hulscher MEJL (2016) Intention to Accept Pertussis Vaccination for Cocooning: A Qualitative Study of the Determinants. PLoS ONE 11(6): e0155861.

Visser O, Kraan J, Akkermans R, Ruiter RA, van der Velden K, Hautvast JL, Hulscher ME. Assessing determinants of the intention to accept a pertussis cocooning vaccination: A survey among Dutch parents. Vaccine. 2016 Aug 11. doi: 10.1016/j.vaccine.2016.07.024.

Bekolo CE, van Loenhout JAF, Rodriguez-Llanes JM, Rumunu J, Ramadan OP, Guha-Sapir D. A retrospective analysis of oral cholera vaccine use, disease severity and deaths during an outbreak in South Sudan. Bull World Health Organ 2016;94:667–674.

Ruijs WLM, van Harten-Gerritsen AS, Akkermans R, de Haan-Burggraaf H, Hautvast JLA. (2016) Rubellascreening bij zwangere vrouwen door verloskundigen. Infectieziekten Bulletin. 2016; 27(8):233-5.

van Oudheusden DEC, Tostmann A, Overgaauw PAM, Hautvast JLA. (2016) Niet-meldingsplichtige zoönosen in de stal. Infectieziekten Bulletin. 2016; 27(8):236-42.

Kampman CJG, Koedijk FDH, Dreissen-Hulshof HCM, Hautvast JLA, van den Broek IVF. (2016) Re: Retesting Chlamydia trachomatis in a GUM clinic in London, UK. Sex Transm Infect 2016.

Curvers M, Freidl G, Hautvast J, Ruijs H, de Melker H, van der Klis F, Tostmann A, Veldhuizen A. (2016) Protection against vaccine-preventable diseases in adult asylum seekers in the Netherlands MT Bulletin of NVTG. 2016; 54(3):19-21.

Curvers M, Tostmann A, Hautvast JLA, Ruijs WLM, de Melker HE, van der Klis F, Freidl G, Veldhuijzen IK. Bescherming tegen infectieziekten bij volwassen asielzoekers. Infectieziekten Bulletin. 2016; 27(8):321-3.

Raven CF, Hautvast JLA, Steenbergen JE, Akkermans R, Weykamp C, Smits F, Hoebe CLPA,  Vossen ACTM. Diagnostic performance of serological assays for anti-HBs testing: Results from a quality assessment program. Journal of Clinical Virology 2016.

van Loenhout JA, Guha-Sapir D. How resilient is the general population to heatwaves? A knowledge survey from the ENHANCE project in Brussels and Amsterdam. BMC Res Notes. 2016;9(1):499.

Niessen W, van Steenbergen J, Waegemaekers T, Hoebe C. Bron- en contactonderzoek bij individuele meldingen; Een aanzet tot een discussie. Infectieziekten bulletin 2016; 27(1):12-14.

van Dam S, Rietveld A, van Hoeven S, Overgaauw P. Hebben dierenspeciaalzaken en dierenasiels een rol in voorlichting over zoonosen? Infectieziekten Bulletin 2016; 27(6):173-4.

van Oudheusden D, van Lier A, van Dam S. Rol van de GGD. Staat van Zoönosen 2015, RIVM. December 2016.

Nic Lochlainn L, Ruijs WL, Swaan C, de Melker H, Hahné S. Response to Lim et al regarding “In-flight transmission of measles: Time to update the guidelines?”. Am J Infect Control. 2016 Nov 9.

de Gier B, van der Maas NAT, Suijkerbuijk A, Ruijs H, te Wierik M. Verschillen in GGD-werkwijzen rond kinkhoestmeldingen Infectieziektenbulletin 2016; 27(2):54-55.

Klomp J, van Lier A, Ruijs WLM. BMR-vaccinatiegraad op Vrije Scholen. Infectieziektenbulletin 2016; 27(5):169-171.

van Rijssel C, Nutma N, Ruijs WLM. Waterpokken in een grootschalige noodopvang. Infectieziektenbulletin 2016; 27(9):286-287.

Belfroid E, Hautvast JLA, Hilbink M, Timen A, Hulscher MEJL. Selection of key recommendations for quality indicators describing good quality outbreak response. BMC Inf Dis 2015: 15: 166.

Van Loenhout JAF, Hautvast JLA, Akkermans RP, Donders NCGM, Vercoulen JH, Paget WJ, van der Velden J. Work participation in Q-fever patients and patients with Legionnaires’ disease: a 12-month cohort study. Scan J PH 2015. DOI: 10.1177/1403494815571030.

Van Loenhout JAF, Hautvast JLA, Vercoulen JH, Akkermans RP, Wijkmans CJ, van der Velden J, Paget WJ. Q-fever patients suffer from impaired health status long after the acute phase of the illness: results from a 24-month cohort study. J Infection 2015; (70) 3: 237-46

van Aart CJC, Braks MAH, Hautvast JLA, de Mast Q, Tostmann A. Dengue en chikungunya bij reizen naar de tropen. NTVG 2015: 159: A8032.

Donkers HW, Hautvast JLA, Akkermans RP, Swaan CM, Ruijs WLM, Hulscher MEJL. Determinants of students’ willingness to accept a measles-mumps-rubella booster vaccination during a mumps outbreak: a cross-sectional study. BMC public health. 2015;15:575.

Meerhoff TJ, Simaku A, Ulqinaku D, Torosyan L, Gribkova N, Shimanovich V, Chakhunashvili G, Karseladze I, Yesmagambetova A, Kuatbayeva A, Nurmatov Z, Otorbaeva D, Lupulescu E, Popovici O, Smorodintseva E, Sominina A, Holubka O, Onyshchenko O, Brown CS, Gross D. Surveillance for severe acute respiratory infections (SARI) in hospitals in the WHO European region – an exploratory analysis of risk factors for a severe outcome in influenza-positive SARI cases. BMC infectious diseases. 2015;15:1

Judd MC, Emukule GO, Njuguna H, McMorrow ML, Arunga GO, Katz MA, Montgomery JM, Wong JM, Breiman RF, Mott JA. The Role of HIV in the Household Introduction and Transmission of Influenza in an Urban Slum, Nairobi, Kenya, 2008-2011. The Journal of infectious diseases. 2015;212(5):740-4.

McMorrow ML, Wemakoy EO, Tshilobo JK, Emukule GO, Mott JA, Njuguna H, Waiboci L, Heraud JM, Rajatonirina S, Razanajatovo NH, Chilombe M, Everett D, Heyderman RS, Barakat A, Nyatanyi T, Rukelibuga J, Cohen AL, Cohen C, Tempia S, Thomas J, Venter M, Mwakapeje E, Mponela M, Lutwama J, Duque J, Lafond K, Nzussouo NT, Williams T, Widdowson MA. Severe Acute Respiratory Illness Deaths in Sub-Saharan Africa and the Role of Influenza: A Case Series From 8 Countries. The Journal of infectious diseases. 2015;212(6):853-60.

McMorrow ML, Emukule GO, Njuguna HN, Bigogo G, Montgomery JM, Nyawanda B, Audi A, Breiman RF, Katz MA, Cosmas L, Waiboci LW, Duque J, Widdowson MA, Mott JA. The Unrecognized Burden of Influenza in Young Kenyan Children, 2008-2012. PloS one. 2015;10(9):e0138272.

Emukule GO, Paget J, van der Velden K, Mott JA. Influenza-Associated Disease Burden in Kenya: A Systematic Review of Literature. PloS one. 2015;10(9):e0138708.

Caini S, Huang QS, Ciblak MA, Kusznierz G, Owen R, Wangchuk S, Henriques CM, Njouom R, Fasce RA, Yu H, Feng L, Zambon M, Clara AW, Kosasih H, Puzelli S, Kadjo HA, Emukule G, Heraud JM, Ang LW, Venter M, Mironenko A, Brammer L, Mai le TQ, Schellevis F, Plotkin S, Paget J, Global Influenza BS. Epidemiological and virological characteristics of influenza B: results of the Global Influenza B Study. Influenza and other respiratory viruses. 2015;9 Suppl 1:3-12.

Morroy G, van der Hoek W, Albers J, Coutinho RA, Bleeker-Rovers CP, Schneeberger PM. Population Screening for Chronic Q-Fever Seven Years after a Major Outbreak. PlosOne 2015 Jul 1;10(7):e0131777. doi: 10.1371/journal.pone.0131777. eCollection 2015

Wielders CC, van Loenhout JA, Morroy G, Rietveld A, Notermans DW, Wever PC, Renders NH, Leenders AC, van der Hoek W, Schneeberger PM. Long-Term Serological Follow-Up of Acute Q-Fever Patients after a Large Epidemic. PloS one. 2015;10(7):e0131848.

Kampman CJG, Koedijk FDH, Driessen-Hulshof HCM, Hautvast JLA, Broek van den IVF.  Retesting young STI clinic visitors with an urogenital Chlamydia trachomatis infection in the Netherlands; response to a text message reminder and reinfection rates: a prospective study with historical controls. STI 2015: accepted

Morroy G, van der Hoek W, Nanver D, Schneeberger PM, Bleeker-Rovers CP, van der Velden J, Coutinho RA. The health status of a village population, seven years after a major Q-fever outbreak. Epi  Inf  2015. doi:10.1017/S0950268815002472

Paget WJ, Aangenend HIM, Kühn MV, Hautvast JLA, van Oorschot DAM, Olde Loohuis A,

van der Velden J, Friedrich AW, Voss A, Köck R. MRSA carriage in community outpatients: a cross-sectional prevalence study in a high-density livestock farming area along the Dutch-German border. PlosOne 2015.

Hegerman-Lindencrone M, Gross D, Meerhoff T, Pereyaslov D, Jorgensen P, Snacken R, Broberg E, Adlhoch C, Beauté J, Penttinen P, Brown C. Performance of the European region influenza

surveillance network: alignment with global standards. Public Health Panorama. 2015;1(1):79-88

Vega T, Lozano JE, Meerhoff T, Snacken R, Beaute J, Jorgensen P, Ortiz de Lejarazu R, Domegan L, Mossong J, Nielsen J, Born R, Larrauri A, Brown C. Influenza surveillance in Europe: comparing intensity levels calculated using the moving epidemic method. Influenza Other Respir Viruses. 2015;9(5):234-46.

Cohen JM, Silva ML, Caini S, Ciblak M, Mosnier A, Daviaud I, Matias G, Badur S, Valette M, Enouf V, Paget J, Fleming DM. Striking Similarities in the Presentation and Duration of Illness of Influenza A and B in the Community: A Study Based on Sentinel Surveillance Networks in France and Turkey, 2010-2012. PLoS One. 2015;10(10):e0139431.

Dorigo-Zetsma JW, Leverstein-van Hall MA, Vreeswijk J, de Vries JJ, Vossen AC, Ten Hulscher HI, Kerkhof J, Smits GP, Ruijs WL, Koopmans MP, Binnendijk RS. Immune status of health care workers to measles virus: evaluation of protective titers in four measles IgG EIAs. J Clin Virol. 2015 Aug;69:214-8.

van Loenhout JA, Wielders CC, Morroy G, Cox MJ, van der Hoek W, Hautvast JL, Paget WJ, van der Velden J. Severely impaired health status of non-notified Q fever patients leads to an underestimation of the true burden of disease. Epidemiol Infect. 2015 Sep;143(12):2580-7.

Klomp JH, van Lier A, Ruijs WL. Vaccination coverage for measles, mumps and rubella in anthroposophical schools in Gelderland, The Netherlands. Eur J Public Health. 2015 Jun;25(3):501-5.

Paget J. Preventing seasonal influenza worldwide through vaccination, education, and international cooperation: research, findings, and recommendations from the Global Influenza Initiative. Influenza Other Respir Viruses. 2015 Aug;9 Suppl 1:1-2.

Silva ML, Perrier L, Cohen JM, Paget WJ, Mosnier A, Spath HM. A literature review to identify factors that determine policies for influenza vaccination. Health Policy (New York). 2015 Jun;119(6):697-708.

van Bijnen EM, Paget J, de Lange-de Klerk ES, den Heijer CD, Versporten A, Stobberingh EE, Goossens H, Schellevis FG. Antibiotic Exposure and Other Risk Factors for Antimicrobial Resistance in Nasal Commensal Staphylococcus aureus: An Ecological Study in 8 European Countries. PLoS One. 2015;10(8):e0135094.

van Dam AS, van Loenhout JA, Peters JB, Rietveld A, Paget WJ, Akkermans RP, Olde Loohuis A, Hautvast JL, van der Velden J. A cross-sectional study to assess the long-term health status of patients with lower respiratory tract infections, including Q fever. Epidemiol Infect. 2015 Jan;143(1):48-54.

van Loenhout JAF. Langetermijneffecten van Q-koorts. Infectieziekten Bulletin. 2015 Okt; 26(8):186-188.

Suijkerbuijk AW, Woudenberg T, Hahné SJ, Lochlainn LN, de Melker HE, Ruijs WL, Lugnér AK. Economic costs of a measles outbreak in The Netherlands, 2013-2014.Emerg Infect Dis. 2015 Nov;21(11):2067-9. doi: 10.3201/eid2111.150410.

van Loenhout J. Gezondheidsstatus Q-koortspatiënten op de lange termijn. Infectious Diseases News International. Maart 2015: 3(1);19.

Waegemaekers CHFM, Bleeker-Rovers CP. Een mogelijke ebola patiënt in de praktijk.

Infectieziekten Bulletin jaargang 26; nr 9-10; 213-214

Richter C, Waegemaekers T, Polling I, Roelofs-Thijssen M. Hepatitis zorg beter regionaal organiseren. Medisch Contact 23 april 2015; 856-858

Ampofo WK, Azziz-Baumgartner E, Bashir U, Cox NJ, Fasce R, Giovanni M, Grohmann G, Huang S, Katz J, Mironenko A, Mokhtari-Azad T, Sasono PM, Rahman M, Sawanpanyalert P, Siqueira M, Waddell AL, Waiboci L, Wood J, Zhang W, Ziegler T; WHO Writing Group. Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014Vaccine. 2015 Aug 26;33(36):4368-82. doi: 10.1016/j.vaccine.2015.06.090. Epub 2015 Jul 3.

De Lange MM, Schimmer B, Vellema P, Hautvast JL, Schneeberger PM, Van Duijnhoven YT. Coxiella burnetii seroprevalence and risk factors in sheep farmers and farm residents in The Netherlands. Epidemiol Infect. 2014 Jun;142(6):1231-44.

Ladbury G, Ostendorf S, Waegemaekers T, van Binnendijk R, Boot H, Hahne S. Smoking and older age associated with mumps in an outbreak in a group of highly-vaccinated individuals attending a youth club party, the Netherlands, 2012. Euro Surveill. 2014;19(16):20776.

Ostendorf SB, Ladbury, G., Hahné, S.J.M., Waegemaekers, C.H.F.M. Bofuitbraak na een feest op een jongerensoos. Inf Bull 2014;25:137-41.

Schimmer B, de Lange MM, Hautvast JL, Vellema P, van Duynhoven YT. Coxiella burnetii seroprevalence and risk factors on commercial sheep farms in The Netherlands. Vet Rec. 2014 Jul 5;175(1):17.

Schimmer B, Schotten N, van Engelen E, Hautvast JL, Schneeberger PM, van Duijnhoven YT. Coxiella burnetii Seroprevalence and Risk for Humans on Dairy Cattle Farms, the Netherlands, 2010-2011. Emerg Infect Dis. 2014 Mar;20(3).

Van Dam ASG, van Loenhout, J.A.F., Peters, J.B., Rietveld, A., Paget, W.J., Akkermans, R.P., OldeLoohuis, A., Hautvast, J.L.A., van der Velden. J. A cross-sectional study to assess the long-term health status of patients with lower respiratory tract infections , including Q-fever. Epidemiology and Infection. 2014:1-7.

van Loenhout JA, van Tiel HH, van den Heuvel J, Vercoulen JH, Bor H, van der Velden K, Paget WJ, Hautvast JL. Serious long-term health consequences of Q-fever and Legionnaires’ disease. J Infect. 2014 Jun;68(6):527-33.

den Heijer CD, van Bijnen EM, Paget WJ, Stobberingh EE. Fusidic acid resistance in Staphylococcus aureus nasal carriage strains in nine European countries. Future Microbiol. 2014 Jun;9(6):737-45.

Raven CF, van Wijngaarden P, Moen G, van Rijen MM. [Cluster outbreak of MRSA in the community; recognition and approach]. Ned Tijdschr Geneeskd. 2014;158(0):A6812.

Richter C, ter Beest G, Gisolf EH, van Bentum P, Waegemaekers C, Swanink C, Roovers E.

Screening for chronic hepatitis B and C in migrants from Afghanistan, Iran, Iraq, the former Soviet Republics, and Vietnam in the Arnhem region, The Netherlands.  Epidemiology and Infection. 2014, Jan 7:1-7. doi:10.1017/S0950268813003415. PMID: 24398373 [Epub ahead of print]

Klomp JHE, van Lier A,  Ruijs WLM. Vaccination coverage for measles, mumps and rubella in anthroposophical schools in Gelderland, The Netherlands. Eur J Public Health. 2015;25(3):501-5

van Loenhout JA, Hautvast JL, Vercoulen JH, Akkermans RP, Wijkmans CJ, van der Velden K, Paget WJ. Q-fever patients suffer from impaired health status long after the acute phase of the illness: results from a 24-month cohort study. J Infect. 2015;70(3):237-46. doi: 10.1016/j.jinf.2014.10.010.

van Loenhout JA, Wielders CC, Morroy G, Cox MJ, van der Hoek W, Hautvast JL, Paget WJ, van der Velden K. Severely impaired health status of non-notified Q fever patients leads to an underestimation of the true burden of disease. Epidemiol Inf 2014. Doi: 10. 1017/S0950268814003689

Emukule GO, Khagayi S, McMorrow ML, Ochola R, Otieno N, et al. (2014) The Burden of Influenza and RSV among Inpatients and Outpatients in Rural Western Kenya, 2009–2012. PLoS ONE 9(8): e105543. doi:10.1371/journal.pone.0105543

C.L. Bekker, H. Aangenend, C.H.F.M. Waegemaekers, W. van der Hoek, J.W. Zenker, A.S.G. van Dam, B. Bom, J.L.A. Hautvast. Landelijke diergegevens, wat kan de GGD ermee?. Inf Bull 2014; 1: 22-24.

Timen A, Ruijs WLM, de Melker HE, van der Have J, Drijfhout I, van der Avoort HG. Poliomyelitis in Syrië: gevolgen voor het Midden-Oosten en voor Nederland. Tijdschrift voor Infectieziekten 2014; 9:134-139. (Tevens overname in Inf Bull 2014;25:248-252).

H.Ruijs en S. Hahné. Mazelen. Bijblijven. Tijdschrift praktische huisartsgeneeskunde 2014;30 (7):30-37.

van Bijnen EM, Paget WJ, den Heijer CD, Stobberingh EE, Bruggeman CA, Schellevis FG; APRES Study Team.Primary. Primary care treatment guidelines for skin infections in Europe: congruence with antimicrobial resistance found in commensal Staphylococcus aureus in the community. BMC Fam Pract. 2014 Oct 25;15(1):175.

van Bijnen EM, Paget J, den Heijer CD, Stobberingh EE, Bruggeman CA, Schellevis FG; APRES study team. Evidence-based primary care treatment guidelines for skin infections in Europe: a comparative analysis. Eur J Gen Pract. 2014 Dec;20(4): 294-300.

Otieno NA, Nyawanda BO, Audi A, Emukule G, Lebo E, Bigogo G, Ochola R, Muthoka P, Widdowson MA, Shay DK, Burton DC, Breiman RF, Katz MA, Mott JA. Demographic, socio-economic and geographic determinants of seasonal influenza vaccine uptake in rural western Kenya, 2011. Vaccine. 2014;32(49):6699-704.

Ndegwa LK, Katz MA, McCormick K, Nganga Z, Mungai A, Emukule G, Kollmann MK, Mayieka L, Otieno J, Breiman RF, Mott JA, Ellingson K. Surveillance for respiratory health care-associated infections among inpatients in 3 Kenyan hospitals, 2010-2012. American journal of infection control. 2014;42(9):985-90.

Katz MA, Muthoka P, Emukule GO, Kalani R, Njuguna H, Waiboci LW, Ahmed JA, Bigogo G, Feikin DR, Njenga MK, Breiman RF, Mott JA. Results from the first six years of national sentinel surveillance for influenza in Kenya, July 2007-June 2013. PloS one. 2014;9(6):e98615.

Njuguna HN, Caselton DL, Arunga GO, Emukule GO, Kinyanjui DK, Kalani RM, Kinkade C, Muthoka PM, Katz MA, Mott JA. A comparison of smartphones to paper-based questionnaires for routine influenza sentinel surveillance, Kenya, 2011-2012. BMC medical informatics and decision making. 2014;14:107.

Emukule GO, McMorrow M, Ulloa C, Khagayi S, Njuguna HN, Burton D, Montgomery JM, Muthoka P, Katz MA, Breiman RF, Mott JA. Predicting mortality among hospitalized children with respiratory illness in Western Kenya, 2009-2012. PloS one. 2014;9(3):e92968.

Morroy G, Wielders CCH, Kruisbergen MJB, van der Hoek W, Marcelis JH, Wegdam-Blans MCA, Wijkmans CJ, Schneeberger PM.  Large Regional Differences in Serological Follow-Up of Q Fever. Patients in The Netherlands. PLoS ONE 2013, 8(4): e60707. oi:10.1371/journal.pone.0060707

Boven van M, Ruijs WLM, Wallinga J, O’Neill PH, Hahne S.  Estimation of vaccine efficacy and critical vaccination coverage in partially observed outbreaks. Plos Compute Biol 2013, 9(5): e1003061. doi:10.1371/journal.pcbi.1003061

Wilhelmina LM Ruijs, Jeannine LA Hautvast, Said Kerrar, Koos van der Velden and Marlies EJL Hulscher. The role of religious leaders in promoting acceptance of vaccination within a minority group: a qualitative study. BMC Public Health BMC Public Health, 2013. 13(1): p. 511.

De Giusti, M., Marinnelli L, et al, Morroy G, La Torre G. Prevalence of Staphylococcus aureus colonization and antibiotic susceptibility: a survey among biomedical students. Public Health, 2013. 127(4): p. 392-4.

den Heijer, C.D., van Bijnen EM, Paget WJ, Pringle M, Goossens H, Bruggeman CH, Schellevis FG, Stobberingh EE, APRES Study team. Prevalence and resistance of commensal Staphylococcus aureus, including meticillin-resistant S aureus, in nine European countries: a cross-sectional study. Lancet Infectious Diseases, 2013. 13(5): p. 409-15.

Schoffelen, T., Joosten LA, Herremans T, de Haan AF, Ammerdorffer A, Rumke HC, Wijkmans CJ, Roest HI, Netea MG, van der Meer JW, Spron T, van Deuren M. Specific Interferon gamma Detection for the Diagnosis of Previous Q Fever. Clinical infectious Diseases 2013. 56(12): p. 1742-51.

Meerhoff T. Contributions to: EuroFlu Weekly Electronic Bulletin, WHO Regional Office for Europe. EuroFlu Weekly Electronic Bulletin, 2013. week 1-20/2013.

Tostmann, A., et al., Pharmacokinetics of first-line tuberculosis drugs in tanzanian patients. Antimicrobial Agents and Chemotherapy, 2013. 57(7): p. 3208-13.

van Dam, S., Advisering over veehouderij en gezondheid aan gemeenten. infectieziekten bulletin, 2013. 24(5).

van Dam, S.T., P. Tolsma, Agrarische kinderopvang? Gezond en veilig! infectieziekten bulletin, 2013. 24(5).

van Loenhout JAF, Paget WJ, Sandker GW, Hautvast JLA, van der Velden J, Vercoulen JH. Assessing health status and quality of life of Q-fever patients: the Nijmegen Clinical Screening Instrument versus the Short Form 36. Health and Quality of Life Outcomes, 2013. 11(1): p. 112.

Vermeiren A.P.A., D.-M.N.H.T.M., Raven C.F.H., van Steenbergen J.E., Hoebe C.J.P.A. Revaccinatie tegen hepatitis B bij non-responders. Resultaten van een retrospectieve studie en opzet van een prospectief onderzoek (RESPONS). Infectieziekten Bulletin, 2013. 24: p. 69-73.

Wielders CCH, Morroy G, Wever PC, Coutinho RA, Schneeberger PM, van der Hoek W Strategies for early detection of chronic Q-fever: a systematic review. European Journal of Clinical Investigation. 03/2013; DOI:10.1111/eci.12073.

Isken LD, Kraaij-Dirkzwager M, Vermeer-de Bondt PE, Rümke HC, Wijkmans C, Opstelten W, Timen A. Implementation of a Q fever vaccination program for highrisk patients in the Netherlands. Vaccine 2013; 31: 2617-22.

de Lange MM, Schimmer B, Vellema P, Hautvast JL, Schneeberger P, van Duijnhoven YT. Coxiella burnetti seroprevalence and risk factors in sheep farmers and farm residents in the Netherlands. Epidemiol Infect 2013; doi:10.1017/S0950268813001726.

Opstelten W, Ruijs WLM, Warris A, van Binnendijk RS, Wolfs TFW, Hahné SJM. Er heerst weer mazelen. NTvG 2013; 157: A6710

Knol M, Urbanus AT, Swart EM, Mollema L, Ruijs WL, van Binnendijk RS, te Wierik MJ, de Melker HE, Timen A, Hahné SJ. Large ongoing measles outbreak in a religious community in the Netherlands since May 2013. Euro Surveill 2013; 18: pii-20580.

Munster JM, Leenders AC, Hamilton CJ, Meekelenkamp JC, Schneeberger PM, van der Hoek W, Rietveld A, de Vries E, Stolk RP, Aarnoudse JG, Hak E. Routine screening for Coxiella burnetti infection during pregnancy: a clustered randomised controlled trial during an outbreak, the Netherlands. Euro Surveill 2013; 18: pii=20504

Klomp J, Siers H, Timmerman-Kok C, Hautvast J. Kenmerken van het handenwasgedrag bij bezoekers van kinderboerderijen. TSG 2013;  5: 277-82.

Hautvast J, Prins M, Zuure F, van Bon-Martens M. Academisering infectieziekten vergt voortzetting academische werkplaatsen. TSG 2013; 6: 313- 4.

Devakumar D, Kitching A, Zenner D, Tostmann A, Meltzer M. Tracking sickness through social networks – the practical use of social network mapping in supporting the management of an E. coli O157 outbreak in a primary school in London. Epidemiol Infect. 2013 Oct;141(10): 2022-30.

Simonsen L, Spreeuwenberg P, Lustig R, Taylor RJ, Fleming DM, Kronemna M, Kerkhove MD van, Mounts AW, Paget WJ,  the GlaMOR Collaboring Teams . (2013) Global Mortality Estimates for the 2009 Influenza Pandemic from the GLaMOR Project: A Modeling Study. PLoS Med 10(11): e1001558. doi:10.1371/journal.pmed.1001558.

Kooistra-Smid AMD, de Boer RF, Croughs PD, Friesema, IHM, Notermans DW, Wolters B, Petrignani M, Zomer TP, Waegemaekers CHFM, Ott A, Rossen JWA, Friedrich AW. Nieuw onderzoek naar diagnostiek van STEC en HUSEC: STEC-ID net. Ned Tijdschrift Medische microbiologie 2013; 21: nr2.

Pelgrim  MTM, Waegemaekers CHFM, Wouters WN, Hautvast JLA.  Een uitbraak van gastro-enteritis in een kinderdagverblijf: de belangrijkste evidence-based hygiëneadviezen op een rij. Infectieziektenbulletin 2013; 8: 229-233.

Verschenen boeken

Kerkhof, H., Steenbergen, J., Mertens, P., Wolters, B., Boer, J. de, Koene, R., Sonder, G. & Hoebe, C.J.P.A. (2012). Infectieziektebestrijding. Den Haag: Boom Lemma uitgevers.

van der Hoek W, Morroy G, Renders NHM, Wever PC, Hermans MHA, Leenders ACAP, Schneeberger PM (2012). Epidemic Q fever in humans in the Netherlands. Coxiella burnetii: Recent Advances and New Perspectives in Research of the Q Fever Bacterium Advances in Experimental Medicine and Biology, 984, doi 10.1007/978-94-007-4315-1_17

RPM Koene, MF Lohuis, J Terpstra, R Wessel. Effectieve verwijzing van chronische hepatitis B-patiënten en bescherming van contacten door de GGD. Infectieziekten Bulletin 2012; 23: 10-14.

H. Aangenend, K. Hoondert. Onderrapportage infectieziekteuitbraken bij kinderdagverblijven.  Infectieziekten Bulletin 2012; 1: 25.

PJ Cornelissen, NAM Leerssen, AJ Tjaden-van der Laan, WLM Ruijs. Risico op de rivier: een norovirusuitbraak op een Riviercruiseschip. Infectieziekten Bulletin 2012; 1: 7-9.

G Morroy, HHJ Bor, J Polder, JLA Hautvast, W van der Hoek, PM Schneeberger, CJ Wijkmans. Self-reported sick leave and long-term health symptoms of Q-fever patients. Eur J Public Health 2012; Febr 7

CFH Raven, JLA Hautvast, T Herremans, AC Leenders, PM Schneeberger. Solitary IgM phase II response has a limited predictive value in the diganosis of acute Q fever. Epidemiol Infect. 2012 Feb 20:1-5. [Epub ahead of print]

B Schimmer, S Luttikholt, JLA Hautvast, EAM Graat, P Vellema, YTHP van Duynhoven. Seroprevalence and risk factors of Q fever in goats on commercial dairy goat farms in the Netherlands, 2009-2010. BMC Veterinary Research 2011, 7:81 doi:10.1186/1746-6148-7-81

Wielders CC, van Binnendijk RS, Snijders BE, Tipples GA Cremer J, Fanoy E, Dolman S, Ruijs W, Boot HJ, de Melker HE, Hahné SJ. Mumps epidemic in orthodox religious low-vaccination communities in the Netherlands and Canada, 2007 to 2009. Euro Surveill 2011, 16: pii=19989.

Snijders BE, Lier EA, van de Kasteele J, Fanoy EB, Ruijs WLM, Hulshof F, Blauwhof A, Schipper M, van Binnendijk R, Boot HJ, de Melker HE, Hahné SJ. Mumps vaccine effectiveness in primary schools and households, the Netherlands, 2008. Vaccine 2012;Feb 27 (Epub ahead of print).

Ruijs WLM, Hautvast JLA, van IJzendoorn G, van Ansem WJC, van der Velden K, Hulscher MEJL. How orthodox Protestant parents decide on the vaccination of their children: a qualitative study. BMC Public Health 2012;12:408.

Ruijs WLM, Hautvast JLA, van Ansem WJ, Akkermans RP, van ’t Spijker K, Hulscher MEJL, van der Velden K. Measuring vaccination coverage in a hard to reach minority. Eur J Public Health 2012;22:359-364.

Nutma N, Gerritsen S, Knops F, Ruijs WLM. Leptospirose: wie is verantwoordelijk voor de rattenbestrijding? Infectieziekten Bulletin 2012;23:137-138.

Martirosyan L, Paget WJ, Jorgensen P, Brown CS, Meerhoff TJ, Pereyaslov D, Mott JA; EuroFlu group. The community impact of the 2009 influenza pandemic in the WHO European region: a comparison with historical seasonal data from 28 countries. BMC Infect Dis. 2012;12: 36.

Rump BO, Visser O, Te Wierik MJ, Vennema H, Fanoy EB. Use of PCR for detection of faecal HAV as a screening tool in an outbreak of hepatitis A in daycare centres. Epidemiol Infect. 2012 May 14:1-7. [Epub ahead of print]

Raven CFH, Augustijn H, Jans HW. Uitbraak van gastro-enteritis onder hulpverleners na een zeer grote brand op een bedrijventerrein. Infectieziekten Bulletin 2012; 6: 166-168.

Hoefnagel J, Weerd DH, van de, Schaefer O, Koene R. A norovirus outbreak triggered by copper intoxication on a coach trip from the Netherlands to Germany, April 2010. Euro Surveill 2012; 17 (9): p11=20104.

Rump Babette O, Woonink F, Fanoy EB. Case Discussion Ethical Questions Concerning the Use of Molecular Typing Techniques in the Control of Infectious Diseases. Public Health Ethics 2012; 5: 311-313.

Ruijs WL, Hautvast JLA, van Ijzendoorn G, van Ansem WJ, Elwyn G, van der Velden K, Hulscher ME. How healthcare professionals respond to parents with religious objections to vaccination: a qualitative study. BMC Health Serv Res. 2012;12:231.

Tostmann A, Bousema T, Oliver I. Investigation of Outbreaks Complicated by Universal Exposure. Emerging Infectious Diseases 2012; 18 (11): 1717-22.

Schimmer B, Lenferink A, Schneeberger P, Aangenend H, Vellema P, Hautvast J, van Duynhoven Y.  Seroprevalence and Risk Factors for Coxiella burnetii (QFever) Seropositivity in Dairy Goat Farmers’ Households in The Netherlands, 2009–2010. PLoS ONE 2012; 7 (7): e42364. Doi:10.1371/journal.pone.0042364.

van Loenhout AF Joris, Paget  W John, Vercoulen H Jan, Wijkmans J Clementine, Hautvast LA Jeannine, van der Velden  Koos. Assessing the long-term health impact of Q-fever in the Netherlands: a prospective cohort study started in 2007 on the largest documented Q-fever outbreak to date. BMC Infect Dis 2012; 12(1): 280.

Vega T, Lozano JE, Meerhoff T, Snacken R, Mott J, Ortiz de Lejarazu  R, Nunes B. Influenza surveillance in Europe: establishing epidemic thresholds by the Moving Epidemic Method. Influenza Other Respi Viruses 2012 Aug 16 doi: 10.1111/j.1750-659.2012.00422.x.

Visser O, Hautvast JLA, Kamp L, van der Velden J, Hulscher MEJL. Cocooning ter preventie van kinkhoest: een haalbare strategie in Nederland? Infectieziekten Bulletin 2012, 8: 243-245.

Hoefnagel JGM, Weerd DH van de, Schaefer O, Krijnen EAJJF, Koene RPM. Een norovirusuitbraak door een kopervergiftiging. Infectieziekten Bulletin 2012; 23: 302-5.

Hoek van der W, Hogema B,  Dijkstra F,  Rietveld A, Wijkmans CJ, Schneeberger PM,  Zaaijer HJ. Relation between Q fever notifications and Coxiella burnetii infections during the 2009 outbreak in the Netherlands. Eurosurveillance, 2012: 17; 20058.

Hoek van der W, P M Schneeberger, T Oomen, M C Wegdam-Blans, F Dijkstra, D W Notermans, H A Bijlmer, K Groeneveld, C J Wijkmans, A Rietveld, L M Kampschreur, Y van Duynhoven. Shifting priorities in the aftermath of a Q fever epidemic in 2007 to 2009 in the Netherlands: from acute to chronic infection. Eurosurveillance 2012; 17: 20059.

Bults M, D J.M.A. Beaujean, CJ. Wijkmans, Aura Timen, Jan Hendrik Richardus, Hélène A.C.M. Voeten. Why did patients with cardiovascular disease in the Netherlands accept Q fever vaccination? Vaccine 2012; 23: 3369–3375.

Ladbury G, Morroy G, Hoeven-Dekkers S, BotermansC, Veelenturf C,  BastiaensM, Abeelen C van,  Wijkmans C. An Outbreak of Scabies in Multiple Linked Healthcare Settings in the Netherlands. Infection Control and Hospital Epidemiology 2012; 33: 1047-1050.

Bults M, D.J.M.A. Beaujean, C.J. Wijkmans, A. Timen, J.H. Richardus, H.A.C.M. Voeten. Q-koortsvaccinatie van hoogrisicopatiënten. Infectieziekten Bulletin 2012: 23; 280-282.

Koningstein M, Groen L, Geraats-Peters K, Lutgens S, Rietveld A, Jira P, Kluytmans J, de Greeff SC, Hermans M, Schneeberger PM. The use of typing methods and infection prevention measures to control a bullous impetigo outbreak  on a neonatal ward. Antimicrob Resist Infect Control 2012; Nov 20;1(1):37. doi: 10.1186/2047-2994-1-37.

Proefschrift: Helma Ruijs. Acceptance of vaccination among orthodox protestant groups in the Netherlands. Enschede, 2012.

Hoff J.H., Oostveen A.M., van Dam A.S.G., van Tilburg-Wolthuis M.
Gezond en veilig op vakantie in Brabant. Infectieziekten bulletin 2011; 22: 14

Morroy G, Peters JB, van Nieuwenhof M, Bor HH, Hautvast JL, van der Hoek W, Wijkmans CJ, Vercoulen JH.
The health status of Q-fever patients after long-term follow-up. BMC Infectious Diseases 2011; 11: 97.

Ruijs WL, Hautvast JL, van der Velden K, de Vos S, Knippenberg H, Hulscher ME .
Religious subgroups influencing vaccination coverage in the Dutch Bible belt: an ecological study.BMC Public Health 2011;11:102.

Ruijs WL, Hautvast JL, van ‘t Spijker K, van der Velden K, Hulscher ME.
Information on vaccination: meeting the needs of unvaccinated youngsters in The Netherlands.Eur J Public Health 2011;21:344-346.

Ruijs WL, Hautvast JL, van Ansem WJ, Akkermans RP, van ’t Spijker K, Hulscher ME, van der Velden K.
Measuring vaccination coverage in a hard to reach minority. Eur J Public Health 2011 Jun 29 (Epub ahead of print)

Van Weel C, Roberts R, De Maeseneer J, Van der Velden K.
Public Health: profession health system governmental control (Comment). The Lancet 2011: 378; 468-9.

Haverkate M, D’Ancona F, Johansen K, Velden van der K, Giesecke J, Lopalco L.
Assessing vaccination coverage in the European Union: is it still al challenge? Expert Rev. Vaccines 2011: 10 (8); 1-xxx.

Ruijs WLM, Hautvast JLA, Akkermans RP, Hulscher ME, van der Velden K.
The role of schools in the spread of Mumps among unvaccinated children: a retrospective cohort study. BMC Inf Dis 2011; 227: 1-7.

Evelien ME van Bijnen, Casper DJ den Heijer, W John Paget, Ellen E Stobberingh, Robert A Verheij, Cathrien A Bruggeman, Mike Pringle, Herman Goossens, Francois G Schellevis
The appropriateness of prescribing antibiotics in the community in Europe: study design. BMC Infectious Diseases 2011; 11: 293

Steffen C, Diop OM, Gessner BD, Hacan MM, Hasser M, Katz MA, Miller MA, Paget WJ, Schoub BD, Vernet G, Ndumbe PM. Afriflu-International conference on influenza disease burden in Africa, 1-2 June 2010, Marrakech, Morocco. Vaccine 2011; 29(3): 363-9.

Veenstra T , Snijders B E, Schimmer B, Rietveld A , Van Dam S, Schneeberger P M, Dijkstra F , Van Der Sande M A, Van Der Hoek W.
Risk Factors for Q Fever in the Netherlands. WebmedCentral INFECTIOUS DISEASES 2011;2(7): WMC002006

R. Nijdam, A.S.G. van Dam.
Informatieblad intensieve veehouderij en gezondheid, update 2011,. GGD Nederland, september 2011.

W van der Hoek, J Meekelenkamp, F Dijkstra, D Notermans, B Bom, P Vellema, A Rietveld, Y van Duynhoven, A Leenders. Proximity to goat farms and coxiella burnetii seroprevalence among pregnant women. Emerging Infectious Diseases, December 2011. F. Dijkstra,

W.v.d.Hoek, N. Wijers, B. Schimmer, A. Rietveld, C. Wijkmans, P. Vellema en P. Schneeberger.
The 2007-2010 Q fever epidemic in the Netherlands: characteristics of notified acute Q fever patients and the association with dairy goat farming. Fems Immunol Med Microbiol: 2011; 1-10

Richter C, ter Beest G, Sancak I, Aydinly R, Bulbul K, Laetemia-tomata F, de Leeuw M, Waegemaekers T, Swaanink C, Roovers E.
Hepatitis B prevalence in the Turkish population of Arnhem: implications for national screening policy? Epidemiol Infect 2011; 11 july; 1-7

Mascini EM, Oldenkamp-Berkelaar C, Schenk A, van Kempen P, Waegemaekers C, Kok WJJ.
Een multidisciplinaire aanpak bij uitbraken van MRSA in een instelling met verstandelijk gehandicapte bewoners. Infectieziekten bulletin 2011; 262-266

Hoefnagel JGM, Cremer J, Koene RP, Boot HJ.
Een niet opgehelderd cluster van acute hepatitis B. Infectieziekten Bull 2011;22:316-18.

Wielders CC, van Binnendijk RS, Snijders BE, Tipples GA, Cremer J, Fanoy E, Dolman S, Ruijs WL, Boot HJ, de Melker HE, Hahné SJ.
Mumps epidemic in orthodox religious low-vaccination communities in The Netherlands and Canada, 2007 to 2009. Eurosurveillance 2011,16: pii=19989.

Euser SM, Brandsema P, Ruijs WLM, den Boer JW.
Legionellabronopsporing in Nederland 2009-2010. Resultaten van de Bronopsporingseenheid Legionellapneumonie. Infectieziektenbulletin 2011;22:160-163.

Ruijs WLM, Cornelissen PJ, Nutma N, Schouten MA.
MRSA in een verzorgingshuis. Infectieziektenbulletin 2011; 22: 267-270.

Schimmer B, Luttikholt S, Hautvast JLA, Graat EAM, Vellema P, van Duynhoven YTHP.
Seroprevalence and risk factors of Q fever in goats on commercial dairy goat farms in the Netherlands, 2009-2010. BMC Veterinary Research 2011, 7:81.

Koene RP, Schimmer B, Rensen H, Biesheuvel M, DE Bruin A, Lohuis A, Horrevorts A, Lunel FV, Delsing CE, Hautvast JL.  A Q fever outbreak in a psychiatric care institution in The Netherlands. Epidemiol Infect. 2010 Feb 9:1-6. [Epub ahead of print]

Paget WJ, Balderston C, Casas I, Donker G, Edelman L, Fleming D, Larrauri A, Meijer A, Puzelli S, Rizzo C, Simonsen L.  EPIA collaborators. Assessing the burden of paediatric influenza in Europe: the European Paediatric Influenza Analysis (EPIA) project.Eur J Pediatr. 2010 Aug;169(8):997-1008. Epub 2010 Mar 13

van der Hoek W, Dijkstra F, Wijers N, Rietveld A, Wijkmans CJ, van Steenbergen JE, Notermans DW, Schneeberger PM.  Three years of Q fever in the Netherlands: faster diagnosis]. Ned Tijdschr Geneeskd. 2010;154(25):A1845. Dutch

Lugnér AK, Mollema L, Ruijs WL, Hahné SJ.  A cost-utility analysis of antenatal screening to prevent congenital rubella syndrome. Epidemiol Infect. 2010 Aug;138(8):1172-84. Epub 2009 Dec 17

van Wijk PT, Schneeberger PM, Heimeriks K, Boland GJ, Karagiannis I, Geraedts J, Ruijs WL.  Occupational blood exposure accidents in the Netherlands. Eur J Public Health. 2010 Jun;20(3):281-7. Epub 2009 Oct 28

Limonard GJ, Nabuurs-Franssen MH, Weers-Pothoff G, Wijkmans C, Besselink R, Horrevorts AM, Schneeberger PM, Groot CA.  One-year follow-up of patients of the ongoing Dutch Q fever outbreak: clinical, serological and echocardiographic findings. Infection. 2010 Sep 21. [Epub ahead of print]

van der Hoek W, Dijkstra F, Wijers N, Rietveld A, Wijkmans CJ, van Steenbergen JE, Notermans DW, Schneeberger PM.  Three years of Q fever in the Netherlands: faster diagnosis. Ned Tijdschr Geneeskd. 2010;154(25):A1845. Dutch

van der Hoek W, Dijkstra F, Schimmer B, Schneeberger PM, Vellema P, Wijkmans C, ter Schegget R, Hackert V, van Duynhoven Y.  Q fever in the Netherlands: an update on the epidemiology and control measures. Euro Surveill. 2010 Mar 25;15(12)

Koene RPM, Hoondert K.  Influenzapandemiedreiging in aanloop naar de Nijmeegse Vierdaagse 2009. Infectiez Bull 2010;21:178-80

Lassche S., Schrauwen M.M.W.P., Rietveld A. en Wijkmans C.J. Huisartsen in hoog-risicogebieden alert op Q-koorts. Infectieziekten Bulletin 2010, 21, nummer 02

M.M.A. de Lange, A.S.G. van Dam, C.J. Wijkmans. Evaluatie van de communicatie naar gemeenten tijdens de Q-koortsepidemie in Noord-Brabant. Infectieziekten bulletin jaargang 21 nummer 901, februari 2010

W.Jeeninga, C. Wijkmans. Q-koortsbestrijding door de GGD; evalueren en leren. Infectiez bull 2010: 21± 342-45

J. Munster , A. Leenders , W. Hoek , P. Schneeberger, A. Rietveld, J. Riphagen-Dalhuisen, R. Stolk, C. Hamilton, E. de Vries, J. Meekelenkamp , J. Lo-Ten-Foe, A. Timmer, L. De Jong – van den Berg,  J. Aarnoudse, E. Hak. Cost-effectiveness of a screening strategy for Q fever among pregnant women in risk areas: a clustered randomized controlled trial. BMC Women’s Health 2010; 10:32

M.F. Verweij, E. de Coster, J. Klomp, L.D. Isken, A. Krom en J.E. van Steenbergen. Mogen gezinsleden van een mazelenpatiënt geweerd worden van school om introductie van de ziekte te voorkomen? Infectiez bull 2010: 21:.273-4

Steffen C, Diop OM, Gessner BD, Hacan MM, Hasser M, Katz MA, Miller MA, Paget WJ, Schoub BD, Vernet G, Ndumbe PM Afriflu–international conference on influenza disease burden in Africa, 1-2 June 2010, Marrakech, Morocco. Vaccine 2011; 29(3): 363-9

Brandsema PS, Euser SME, Ruijs WLM. Legionellose-uitbraken en -clusters: speuren naar de bron. Bijblijven 2010 (26) nr 7

R.P.M. van Kessel, C.H.F.M. Waegemaekers. Surveillance binnen de algemene infectieziektebestrijding bij de regionale GGD. Infectiez bull 2010; 21: 364-67

Koene RPM, Gotz, HM, Van den Hoek JAR, Heijen ML, Van Steenbergen JA, Kroes ACM.  Significance of isolated antibody to hepatitis B core antigen in Dutch national vaccination campaign of behavioural high-risk groups. Epidemiol Infect 2009; 137(4):495-503

Ouwerkerk IMS van, Waegemaekers CHFM  Evaluatie van een botulismecluster met behulp van een geneeriek evaluatiekader voor infectieziekteuitbraken. Infectieziektenbulletin 2009; nr. 3 (98-102)

Ouwerkerk IMS van, Dam M van, Ransz WJG, Waegemaekers CHFM, Timen A, Timmer MS, Berends C. Coördinatie en communicatie in tijden van grieppandemie. Infectieziektenbulletin 2009; nr. 7 (227-231)

Bolwerk,  Morroy G, Wijkmans C.  Uit het veld, scout op herhaling:  infectieziekten bulletin,  juni 2009; 20(5)

Dofferhoff ASM, Koene RPM, van Zanten  N, van Gurp T, Muurling-Koppers ACE, van der Ven AJAM en van Hattum J.  Hepatitis C treatment in drug users in the Nijmegen district. Tijdschr Infect 2009;4:96-102. Dutch.

Fransen, G., Molleman, GRM., Hekkink C., Keijser. JFEM.  Trendonderzoek Gezondheidsbevordering en Preventie 2008. NIGZ-Centrum voor Kennis en Kwaliteit, Woerden.

Friesema IH, Vennema H, Heijne JC, de Jager CM, Morroy G, van den Kerkhof JH, de Coster EJ, Wolters BA, ter Waarbeek HL, Fanoy EB, Teunis PF, van der Linde R, van Duynhoven YT.  Norovirus outbreaks in nursing homes: the evaluation of infection control measures. Epidemiol Infect. 2009 Dec;137(12):1722-33. Epub 2009 May 11.PMID: 19426572

Heijne JC, Teunis P, Morroy G, Wijkmans C, Oostveen S, Duizer E, Kretzschmar M, Wallinga J.  Enhanced hygiene measures and norovirus transmission during an outbreak. Emerg Infect Dis. 2009 Jan;15(1):24-30.PMID: 19116045

Karagiannis I, Schimmer B, van Lier A, Timen A, Schneeberger P, van Rotterdam B,  de Bruin A, Wijkmans C, Rietveld A, van Duynhoven Y.  Investigation of a Q fever outbreak in a rural area of the Netherland. Epidemiologic infection, 2009, 1-12

Meijer A, Lackenby A, Hungnes O, Lina B, van-der-Werf S, Schweiger B, Opp M, Paget J, van-de-Kassteele J, Hay A, Zambon M.  European Influenza Surveillance Scheme. Oseltamivir-resistant influenza virus A(H1N1), Europe, 2007-2008 season. Emerging Infectious Diseases 2009 Apr; 15(4):552-60

Meekelenkamp J, Notermans D, Rietveld A, Marcelis J,  Schimmer B, Reimerink J, Vollebergh J, Wijkmans C, Leenders A. Seroprevalentie van Coxiella burnetii bij zwangeren in Noord-Brabant in 2007. Infectieziekten Bulletin 2009, maart; 20(2): 57 -61

Meerhoff TJ, Mosnier A. Schellevis F, Paget WJ.  Progress in the surveillance of respiratory syncytial virus (RSV) in Europe: 2001-2008. Eurorsurveillance 2009 Oct 8; 14 (40)

Meerhoff TJ, Paget WJ, Kimpen JLL, Schellevis F.  Variation of respiratory syncytial virus and the relation with metereological factors in different winter seasons. Pediatric Infectious Disease Journal 2009; 28(10): 860-866

Molleman, GRM and Franse LM  The struggle for abandonment of Femela Genital Mutilation/Cutting (FGM/C) in Egypt. Global Health Promotion 16, 57-60

Paget, J. The influenza pandemic and Europe: the social impact and public health response. Italian Journal of Public Health 2009; 6(3): 257-259

van Ouwerkerk IMS, van Dam M,  Ransz WJG, Waegemaekers  CHFM en  Timen A.  Coördinatie en communicatie in tijden van grieppandemie. Infectieziekten Bulletin 2009; 20(7)

van Ouwerkerk IMS, Waegemaekers CHFM.  Evaluatie van een botulismecluster met behulp van een generiek evaluatiekader voor infectieziekteuitbraken. Infectieziekten Bulletin 2009; 20(3)

Rietveld A, van.Dam A, Wijkmans C.  Praktische aspecten van onderzoek bij zwangeren tijdens de eerste Q-koortsuitbraak in 2007. Infectieziekten Bulletin 2009, maart; 20( 2);, 44 – 45

Ruijs WLM, Hulscher MEJL, Hahne SJM,  Van Binnendijk RS, Van der Velden J.  Feasibility of a rubella screening and vaccination programme for unvaccinated young women Epidemiol Infect 2009; 4:1-4. PMID: 19192319

Hahne S, Macey J, van Binnendijk R, Kohl R, Dolman S, van der Veen Y, Tipples G, Ruijs H, Mazulli T, Timen A, van Loon A, de Melker H.  Rubella Outbreak in the Netherlands, 2004-2005: High Burden of Congenital Infection and Spread to Canada. Pediatr Infect Dis J 2009 September;28(9):795-800

Houwers DJ, Wagenaar JA, Hartskeerl RA, Hautvast JLA, Stinis HP, Ruijs WLM, Lenaers SJM. Leptospirose (ziekte van Weil) bij de hond: een risico voor de mens? Tijdschr Diergeneeskd 2009;134:392-394

Ruijs WLM, van Wijk PThL.  Prikaccidenten in de arbeidssituatie. Infectieziektenbulletin 2009(20) nr.4

Euser SM, Brandsema P, Ruijs WLM, den Boer JW. Resulaten van de Bronopsporings Eenheid Legionella Pneumonie (BEL) 2007-2008. Infectieziektenbulletin 2009 (20) nr. 6

Lugner AK, Mollema L, Ruijs WLM, Hahne SJM. A cost-utility analysis of antenatal screening to prevent congenital rubella syndrome. Epidemiol Infect 2009 December 17;1-13.(Epub ahead of print)

van Wijk PThL, Schneeberger PM, Heimeriks K, Boland GJ, Karagiannis I, Geraedts J, Ruijs WLM. Occupational blood exposure accidents in the Netherlands. Eur J Pub Health 2009 Oct 28. (Epub ahead of print)

Fleming DM, Elliot AJ, Meijer A, Paget WJ.  Influenza resistance to Oseltamivir: what are the implications? European Journal of Public Health 2009 Feb 12. [Epub ahead of print]

Ciancio BC, Meerhoff TJ, Kramarz P, Bonmarin I, Borgen K, Boucher CA, Buchholz U, Buda S, Dijkstra F, Dudman S, Duwe S, Hauge SH, Hungnes O, Meijer A, Mossong J, Paget WJ, Phin N, van der Sande M, Schweiger B, Nicoll A. Oseltamivir-resistant influenza A(H1N1) viruses detected in Europe during season 2007-8 had epidemiologic and clinical characteristics similar to co-circulating susceptible A(H1N1) viruses. Eurosurveillance 2009 Nov 19;14(46). pii: 19412

Fleming DM, Elliot AJ, Meijer A, Paget WJ.  Influenza resistance to Oseltamivir: what are the implications? European Journal of Public Health 2009 Jun;19(3):238-9

Koene RP, Gotz HM, Van Den Hoek JA, Heijnen ML, Van Steenbergen JA, Kroes AC. Significance of isolated antibody to hepatitis B core antigen in Dutch national vaccination campaign of behavioural high-risk groups. Epidemiol Infect. 2009 Apr;137(4):495-503. Epub 2008 Jul 23.PMID: 18647436

1.Arkema JM, Meijer A, Paget WJ, van Casteren V, Hungnes O, Mazick A, van der Velden J. The influenza season has started in a number of European countries. Euro Surveill 2008;13(4)

Burg J, Van der Maas PJ, Roscam Abbing EW. Primaire preventie. In: Mackenbach J, Van der Maas PJ (eds). Volksgezondheid & Gezondheidszorg. Maarssen: Elvesier, 2008.

Drenthen AJM, Assendelft WJJ, van der Velden J. Preventie in de huisartsenpraktijk: kom in beweging! Huisarts Wet 2008;51(1):38-41

Karagiannis I, Van Lier A, van Binnendijk R, Ruijs H, Fanoij E, Conyn-van Spaendonk MAE, Melker H, Hahné S.  Mumps in a community with low vaccination coverage in the Netherlands. Eurosurveillance Wkly 2008;13(24)

Ruijs WLM, Hautvast JLA, Jansen I, Oude Vrielink P, van der Velden J.  De vaccinatiestatus van kinderen van kermisexploitanten. JGZ 2008;40:11-15

Ruijs WLM, Hautvast JLA, Jansen I, Oude Vrielink P, van der Velden J. De vaccinatiestatus van kinderen van kermisexploitanten. Infectiez Bull 2008;19(176):180

Terpstra JS, Kutschenreuter AE, Furer JW, de Jong VCEJ, van der Velden J. Hatert=gezond?! Een model in ontwikkeling. Tijdschr Gezondheidswet 2008;86(2 – NCVGZ):96

Van der Velden J. De arts in de samenleving van morgen. In: Kirkels V (ed). Oude idealen in de nieuwe zorgmarkt. Nijmegen: Valkhof Pers, 2008.

Van der Velden J., H. Hoek Governance & Gezondheidszorg. Private, publieke en professionele invloeden op zorgaanbieders in Nederland [boekbespreking]. Ned Tijdschr Geneeskd 2008;152:410-411

Van der Velden J. Internationale gezondheid. In: Mackenbach J, Van der Maas PJ (eds). Volksgezondheid & Gezondheidszorg. Maarssen: Elvesier, 2008.

Van der Velden J. Met het oog op de wereldgezondheid: goed, slecht en minder fraai nieuws. Tijdschr Gezondheidswet 2008;86(1):4-5

Arkema JMS, Meerhoff TJ, Paget WJ, Meijer A, Ansaldi F, Buchholz U, Fleming DM, Nicoll A, van der Velden J. Seasonal influenza activity in Europe: declining in most countries in the West but increasing in the North East. Eurosurveillance Wkly 2007;12(30)

Arkema JMS, Paget WJ, Meijer A, Meerhoff TJ, Ansaldi F, Buchholz U, Fleming DM, Nicoll A, van der Velden J.  Seasonal influenza beginning in Europe: report from EISS. Eurosurveillance Wkly 2007;12(4)

Koene R, Hautvast J, Züchner L, Voorn P, Rooyackers-Lemmens E, Noel H, Swaan C. Local cluster of psittacosis after bird show in the Netherlands, November 2007. Eurosurveillance Wkly 2007;12(12):E071213

Meijer A, Paget WJ, Meerhoff TJ, Brown C, Meusissen LE, van der Velden J.  Epidemiological and virological assessment of influenza activity in Europe during the 2005-2006 winter. Eurosurveillance Mthly 2007;12(9)

Paget WJ, Marquet R, Meijer A, Van der Velden K. Influenza activity during eight seasons (1999-2007): an evaluation of the indicators used to measure activity snd an assessment of the timing, length and course of peak activity (spread) of influenza across Europe. BMC Infectious Diseases 2007;7(141)

Van der Velden J. Regie in preventie: een ontwerp voor public health beleid. In: Boot JM (ed). Jaarboek Publieke Gezondheid 2007.

Arkema JMS, Meerhoff TJ, Paget WJ, Meijer A, Ansaldi F, Buchholz U, Fleming DM, Nicoll A, van der Velden J. Seasonal influenza activity in Europe: declining in most countries in the West but increasing in the North East. Eurosurveillance Wkly 2007;12(30)

Arkema JMS, Paget WJ, Meijer A, Meerhoff TJ, Ansaldi F, Buchholz U, Fleming DM, Nicoll A, van der Velden J.  Seasonal influenza beginning in Europe: report from EISS. Eurosurveillance Wkly 2007;12(4)

Koene R, Hautvast J, Züchner L, Voorn P, Rooyackers-Lemmens E, Noel H, Swaan C. Local cluster of psittacosis after bird show in the Netherlands, November 2007. Eurosurveillance Wkly 2007;12(12):E071213

Meijer A, Paget WJ, Meerhoff TJ, Brown C, Meusissen LE, van der Velden J.  Epidemiological and virological assessment of influenza activity in Europe during the 2005-2006 winter. Eurosurveillance Mthly 2007;12(9)

Paget WJ, Marquet R, Meijer A, Van der Velden K. Influenza activity during eight seasons (1999-2007): an evaluation of the indicators used to measure activity snd an assessment of the timing, length and course of peak activity (spread) of influenza across Europe. BMC Infectious Diseases 2007;7(141)

Van der Velden J. Regie in preventie: een ontwerp voor public health beleid. In: Boot JM (ed). Jaarboek Publieke Gezondheid 2007.

Hahné S, Macey J, Tipples G, Varughese P, King A, van Binnendijk R, Ruijs H, van Steenbergen J, Timen A, van Loon AM, de Melker H. Rubella outbreak in an unvaccinated religious community in the Netherlands spreads to Canada. Euro Surveill 2005;10(5):E050519

Hahné S, Ward M, Abbink F, van Binnendijk R, Ruijs H, van Steenbergen J, Timen A, de Melker H. Large ongoing rubella outbreak in religious community in the Netherlands since September 2004. Euro Surveill 2005;10(3):E050303

Hahné SJM, Abbink F, van Binnendijk RS, Ruijs WLM, van Steenbergen JE, de Melker HE. Rubella-epidemie in Nederland in 2004/’05: alertheid op congenitaal rubellasyndroom vereist. Ned Tijdschr Geneeskd 2005;149(21):1174-1178

Meijer A, Valette M, Manuguerra JC, Perez-Brena P, Paget J, Brown C, van der Velden J.  Implementation of the community network of reference laboratories for human influenza in Europe. J Clin Virol 2005;34(2):87-96

Paget WJ, Meerhoff TJ, Meijer A, van der Velden J. Five winters of influenza activity in Europe : an evaluation of the indicators used to measure the activity and an assessment of timing, length and spreading of influenza. Eurosurveillance Weekly 2005;10(44)

Saito R, Paget WJ, Hitaka S, Sakai A, van der Velden K. Geographic mapping method shows potential for influenza mapping in Europe. Eurosurveillance Weekly 2005;10(40)

van der Veen Y, Hahné S, Ruijs H, van Binnendijk R, Timen A, van Loon AM, de Melker H. Rubella outbreak in an unvaccinated religious community in the Netherlands leads to cases of congenital rubella syndrome. Eurosurveillance Weekly 2005;10(11):E051124

Van der Velden J. De huidige gezondheidszorg: te veel individuele zorg te weinig volksgezondheid. Psychosoc Oncol 2005;10:19-21

Meerhoff TJ, Paget WJ, Aguilera JF, van der Velden J.  Harmonising the virological surveillance of influenza in Europe: results of an 18-country survey. Virus Res 2004;103(1-2):31-33

Paget WJ, Meerhoff TJ, Meijer A, van der Velden J.  Analysis of EISS database reveals possible west-east spread of influenza across Europe. Eurosurveillance Wkly 2004;8(47):4-5

Aguilera JF, Paget WJ, Mosnier A, Heijnen ML, Uphoff H, van der Velden J, Vega T, Watson JM. Heterogeneous case definitions used for the surveillance of influenza in Europe. Eur J Epidemiol 2003;18(8):751-754

Delnoij DM, Klazinga NS, van der Velden J. Building integrated health systems in central and eastern Europe: an analysis of WHO and World Bank views and their relevance to health systems in transition. Eur J Public Health 2003;13(3):240-245

Fleming DM, van der Velden J, Paget WJ.  The evolution of influenza surveillance in Europe and prospects for the next 10 years. Vaccine 2003;21(16):1749-1753